Form 8-K - Current report:
SEC Accession No. 0001674930-26-000025
Filing Date
2026-05-21
Accepted
2026-05-21 17:04:12
Documents
10
Period of Report
2026-05-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flgt-20260521.htm   iXBRL 8-K 47314
2 EX-99.1 flgt-ex99_1.htm EX-99.1 17411
  Complete submission text file 0001674930-26-000025.txt   173493

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20260521.xsd EX-101.SCH 25206
13 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20260521_htm.xml XML 4527
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

EIN.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 261009654
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)